EUVIMEDEUVIMED entdecken
Querschnittstudie

ASSOCIATION BETWEEN SERUM MYOSTATIN LEVELS AND SARCOPENIA IN MIDDLE-AGED ADULTS: A CROSS-SECTIONAL STUDY

Mahwish Israr, Zubia Shah, Omar Malik, Farida Ahmad

Khyber Journal of Medical Sciences · 31.03.2026 · 19 (1)

DOI: 10.70520/kjms.v19i1.772 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Khyber Journal of Medical Sciences, online erschienen am 31.03.2026. Verfasst von Mahwish Israr und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myostatin levels in individuals increase with age, resulting in reduced muscle mass and decreased strength, which contributes to the development of sarcopenia.

Objectives

To find and compare the levels of Myostatin in middle-aged Sarcopenic and non-Sarcopenic individuals. Materials and Methods: Material and Methods: This cross-sectional study employed purposive sampling and was conducted in the Department of Physiology at Khyber Medical University from October 26, 2023, to March 19, 2024. The OpenEpi software was used to determine the sample size with 80% power and a 95% confidence level. Ninety-two volunteers (male=58, female=34) were included in the study, which used the SWAG-SARCO 2021. Myostatin levels were measured using an enzyme-linked immunosorbent assay. The exercise tests were performed in the skill labs at IBMS, KMU, and BKMC Mardan.

Results

A statistically significant difference (p < 0.05) was observed between the patients in the Sarcopenia group and those in the non-Sarcopenia group regarding MUAC, TSF, CC, height, weight, and BMI. In addition, a statistically significant difference (p < 0.05) was also found between the sarcopenia group and the non-sarcopenia group in terms of SPPB, Grip strength, IRM-Knee extension, weightlifting, Quad stretch, and TUG test. The mean myostatin levels between the sarcopenic and non-sarcopenic groups were also statistically significant (p = 0.001).

Conclusion

This study showed that even among middle-aged individuals, myostatin levels may increase, leading to an involuntary loss of skeletal muscle strength and mass known as sarcopenia.

Zitieren

APA

Israr, M., Shah, Z., Malik, O., & Ahmad, F. (2026). ASSOCIATION BETWEEN SERUM MYOSTATIN LEVELS AND SARCOPENIA IN MIDDLE-AGED ADULTS: A CROSS-SECTIONAL STUDY. Khyber Journal of Medical Sciences, 19(1). https://doi.org/10.70520/kjms.v19i1.772

Vancouver

Israr M, Shah Z, Malik O, Ahmad F. ASSOCIATION BETWEEN SERUM MYOSTATIN LEVELS AND SARCOPENIA IN MIDDLE-AGED ADULTS: A CROSS-SECTIONAL STUDY. Khyber Journal of Medical Sciences. 2026;19(1). doi:10.70520/kjms.v19i1.772

BibTeX
@article{Israr2026,
  author = {Israr, Mahwish and Shah, Zubia and Malik, Omar and Ahmad, Farida},
  title = {ASSOCIATION BETWEEN SERUM MYOSTATIN LEVELS AND SARCOPENIA IN MIDDLE-AGED ADULTS: A CROSS-SECTIONAL STUDY},
  journal = {Khyber Journal of Medical Sciences},
  year = {2026},
  volume = {19},
  number = {1},
  doi = {10.70520/kjms.v19i1.772}
}
Kostenlos starten →